Toluene-4-sulfonic acid (1R,2R,3S,4R,4aR,11bS)-2,3-dihydroxy-4-(4-methoxy-benzyloxy)-2,3,4,4a,6,11b-hexahydro-1H-5,8,10-trioxa-cyclopenta[b]phenanthren-1-yl ester

Base Information

Chemical Name:Toluene-4-sulfonic acid (1R,2R,3S,4R,4aR,11bS)-2,3-dihydroxy-4-(4-methoxy-benzyloxy)-2,3,4,4a,6,11b-hexahydro-1H-5,8,10-trioxa-cyclopenta[b]phenanthren-1-yl ester
CAS No.:173425-91-7
Molecular Formula:C₂₉H₃₀O₁₀S
Molecular Weight:570.617
Hs Code.:

Toluene-4-sulfonic acid (1R,2R,3S,4R,4aR,11bS)-2,3-dihydroxy-4-(4-methoxy-benzyloxy)-2,3,4,4a,6,11b-hexahydro-1H-5,8,10-trioxa-cyclopenta[b]phenanthren-1-yl ester

Synonyms:Toluene-4-sulfonic acid (1R,2R,3S,4R,4aR,11bS)-2,3-dihydroxy-4-(4-methoxy-benzyloxy)-2,3,4,4a,6,11b-hexahydro-1H-5,8,10-trioxa-cyclopenta[b]phenanthren-1-yl ester

Suppliers and Price of Toluene-4-sulfonic acid (1R,2R,3S,4R,4aR,11bS)-2,3-dihydroxy-4-(4-methoxy-benzyloxy)-2,3,4,4a,6,11b-hexahydro-1H-5,8,10-trioxa-cyclopenta[b]phenanthren-1-yl ester

Supply Marketing:

Business phase:: The product has achieved commercial mass production^*data from LookChem market partment

Manufacturers and distributors:

Manufacture/Brand
Chemicals and raw materials
Packaging
price

Total 0 raw suppliers

Chemical Property of Toluene-4-sulfonic acid (1R,2R,3S,4R,4aR,11bS)-2,3-dihydroxy-4-(4-methoxy-benzyloxy)-2,3,4,4a,6,11b-hexahydro-1H-5,8,10-trioxa-cyclopenta[b]phenanthren-1-yl ester

Chemical Property:

Purity/Quality:

Safty Information:

Pictogram(s):
Hazard Codes:

MSDS Files:

Useful:

Technology Process of Toluene-4-sulfonic acid (1R,2R,3S,4R,4aR,11bS)-2,3-dihydroxy-4-(4-methoxy-benzyloxy)-2,3,4,4a,6,11b-hexahydro-1H-5,8,10-trioxa-cyclopenta[b]phenanthren-1-yl ester

There total 10 articles about Toluene-4-sulfonic acid (1R,2R,3S,4R,4aR,11bS)-2,3-dihydroxy-4-(4-methoxy-benzyloxy)-2,3,4,4a,6,11b-hexahydro-1H-5,8,10-trioxa-cyclopenta[b]phenanthren-1-yl ester which guide to synthetic route it. The literature collected by LookChem mainly comes from the sharing of users and the free literature resources found by Internet computing technology. We keep the original model of the professional version of literature to make it easier and faster for users to retrieve and use. At the same time, we analyze and calculate the most feasible synthesis route with the highest yield for your reference as below:

synthetic route:

Reference yield: 95.0%

: 173425-90-6
C₃₅H₃₈O₁₀S

: 173425-91-7
Toluene-4-sulfonic acid (1R,2R,3S,4R,4aR,11bS)-2,3-dihydroxy-4-(4-methoxy-benzyloxy)-2,3,4,4a,6,11b-hexahydro-1H-5,8,10-trioxa-cyclopenta[b]phenanthren-1-yl ester

Guidance literature:: With hydrogenchloride; In methanol;
DOI:10.1016/0040-4039(95)02070-5

Reference yield:

: 5434-47-9
5-bromo-6-bromomethylbenzo[1,3]dioxole

: 173425-91-7
Toluene-4-sulfonic acid (1R,2R,3S,4R,4aR,11bS)-2,3-dihydroxy-4-(4-methoxy-benzyloxy)-2,3,4,4a,6,11b-hexahydro-1H-5,8,10-trioxa-cyclopenta[b]phenanthren-1-yl ester

Guidance literature:: Multi-step reaction with 4 steps

1: 98 percent / NaH / dimethylformamide

2: 64 percent / n-BuLi / diethyl ether / -78 °C

3: 84 percent / pyridine

4: 95 percent / 6N HCl / methanol

With pyridine; hydrogenchloride; n-butyllithium; sodium hydride; In methanol; diethyl ether; N,N-dimethyl-formamide;
DOI:10.1016/0040-4039(95)02070-5

Reference yield:

: 34361-60-9,55123-24-5,55123-26-7,62012-78-6,104873-71-4
1L-1,2:4,5-di-O-cyclohexylidene-myo-inositol

: 173425-91-7
Toluene-4-sulfonic acid (1R,2R,3S,4R,4aR,11bS)-2,3-dihydroxy-4-(4-methoxy-benzyloxy)-2,3,4,4a,6,11b-hexahydro-1H-5,8,10-trioxa-cyclopenta[b]phenanthren-1-yl ester

Guidance literature:: Multi-step reaction with 8 steps

1: 76 percent / pyridine

2: 90 percent / NaH

3: 83 percent / p-TsOH, EtOH / CH₂Cl₂

4: 93 percent / sodium methoxide / methanol / Heating

5: 98 percent / NaH / dimethylformamide

6: 64 percent / n-BuLi / diethyl ether / -78 °C

7: 84 percent / pyridine

8: 95 percent / 6N HCl / methanol

With pyridine; hydrogenchloride; n-butyllithium; ethanol; sodium methylate; sodium hydride; toluene-4-sulfonic acid; In methanol; diethyl ether; dichloromethane; N,N-dimethyl-formamide;
DOI:10.1016/0040-4039(95)02070-5